Pages

Monday, June 17, 2019

Pluristem Strengthens Its Manufacturing Competitive Advantage, Presents its First Proprietary Serum-Free Cell Therapy Product - GlobeNewswire

Pluristem Strengthens Its Manufacturing Competitive Advantage, Presents its First Proprietary Serum-Free Cell Therapy Product  GlobeNewswire

This marketing grade serum-free media enables Pluristem large-scale, highly consistent production with operational independency from third party suppliers.


Pluristem Strengthens Its Manufacturing Competitive Advantage, Presents its First Proprietary Serum-Free Cell Therapy Product - GlobeNewswire
Read More

No comments:

Post a Comment